Cargando…

Intravaginal HPV DNA vaccination with electroporation induces local CD8+ T-cell immune responses and antitumor effects against cervicovaginal tumors

Therapeutic human papillomavirus (HPV) vaccines have the potential to inhibit the progression of an established HPV infection to precancer and cancer lesions by targeting HPV oncoproteins. We have previously developed a therapeutic DNA vaccine encoding calreticulin (CRT) linked to E7, CRT/E7 DNA vac...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sun, Y, Peng, S, Qiu, J, Miao, J, Yang, B, Jeang, J, Hung, C-F, Wu, T-C
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2015
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4490060/ https://www.ncbi.nlm.nih.gov/pubmed/25786869 http://dx.doi.org/10.1038/gt.2015.17

Ejemplares similares

Coinjection of IL2 DNA enhances E7-specific antitumor immunity elicited by intravaginal therapeutic HPV DNA vaccination with electroporation
por: Sun, Yunyan, et al.
Publicado: (2017)

Intravaginal live attenuated Salmonella increase local antitumor vaccine-specific CD8(+) T cells
por: Decrausaz, Loane, et al.
Publicado: (2013)

Buccal injection of synthetic HPV long peptide vaccine induces local and systemic antigen-specific CD8+ T-cell immune responses and antitumor effects without adjuvant
por: Yang, Ming-Chieh, et al.
Publicado: (2016)

Association of HPV infection and clearance with cervicovaginal immunology and the vaginal microbiota
por: Shannon, B, et al.
Publicado: (2017)

Longitudinal analysis on the ecological dynamics of the cervicovaginal microbiome in hrHPV infection
por: Molina, Mariano A., et al.
Publicado: (2023)

A pro-inflammatory CD8+ T-cell subset patrols the cervicovaginal tract
por: Pattacini, Laura, et al.
Publicado: (2019)

Cervicovaginal microbiome and natural history of HPV in a longitudinal study
por: Usyk, Mykhaylo, et al.
Publicado: (2020)

Diversity of cervicovaginal human papillomavirus (HPV) genotypes and naturally occurring E6/E7 DNA polymorphisms of HPV-16 in Ghana
por: Kaba, Gladys, et al.
Publicado: (2023)

Assessing the Cervicovaginal Microbiota in the Context of hrHPV Infections: Temporal Dynamics and Therapeutic Strategies
por: Molina, Mariano A., et al.
Publicado: (2022)

Local administration of granulocyte macrophage colony-stimulating factor induces local accumulation of dendritic cells and antigen-specific CD8+ T cells and enhances the efficacy of therapeutic vaccine in cervicovaginal tumor
por: Lee, Sung-Jong, et al.
Publicado: (2015)

Intravaginal TLR agonists increase local vaccine-specific CD8 T-cells and human papillomavirus-associated genital-tumor regression in mice
por: Domingos-Pereira, Sonia, et al.
Publicado: (2012)

Treatment with Imiquimod enhances antitumor immunity induced by therapeutic HPV DNA vaccination
por: Chuang, Chi-Mu, et al.
Publicado: (2010)

Concordance in HPV Detection Between Self-Collected and Health Provider–Collected Cervicovaginal Samples Using careHPV in Tanzanian Women
por: Katanga, Johnson J., et al.
Publicado: (2021)

Deciphering the complex interplay between microbiota, HPV, inflammation and cancer through cervicovaginal metabolic profiling
por: Ilhan, Zehra Esra, et al.
Publicado: (2019)

Comparison of Analytical and Clinical Performance of HPV 9G DNA Chip, PANArray HPV Genotyping Chip, and Hybrid-Capture II Assay in Cervicovaginal Swabs
por: Jung, Ho Young, et al.
Publicado: (2016)

The Interplay Between Cervicovaginal Microbial Dysbiosis and Cervicovaginal Immunity
por: Wang, Ya, et al.
Publicado: (2022)

Antitumor Response and Immunomodulatory Effects of Sub-Microsecond Irreversible Electroporation and Its Combination with Calcium Electroporation
por: Novickij, Vitalij, et al.
Publicado: (2019)

In-depth insights into cervicovaginal microbial communities and hrHPV infections using high-resolution microbiome profiling
por: Molina, Mariano A., et al.
Publicado: (2022)

Transience of cervical HPV infection in sexually active, young women with normal cervicovaginal cytology.
por: Hinchliffe, S. A., et al.
Publicado: (1995)

Infection and vaccine-induced HPV-specific antibodies in cervicovaginal secretions. A review of the literature
por: Pattyn, Jade, et al.
Publicado: (2019)

Changes in the cervicovaginal microbiota composition of HPV16‐infected patients after clinical treatment
por: Li, Chao, et al.
Publicado: (2022)

Citodiagnóstico cervicovaginal /
por: Olvera Rodríguez, Arturo
Publicado: (2009)

"Leucorreas" (cervicovaginitis)/
por: Plácido Islas, María Rebeca
Publicado: (1994)

Decontamination of Intravaginal Probes Infected by Human Papillomavirus (HPV) Using UV-C Decontamination System
por: Pichon, Maxime, et al.
Publicado: (2019)

Linking cervicovaginal immune signatures, HPV and microbiota composition in cervical carcinogenesis in non-Hispanic and Hispanic women
por: Łaniewski, Paweł, et al.
Publicado: (2018)

Electroporation-Mediated DNA Vaccination
por: Fagone, Paolo, et al.
Publicado: (2010)

Cervicovaginal microbiota significantly changed for HPV-positive women with high-grade squamous intraepithelial lesion
por: Guo, Chunlei, et al.
Publicado: (2022)

DNA methylation signatures to predict the cervicovaginal microbiome status
por: Nené, Nuno R., et al.
Publicado: (2020)

Vascular disrupting agent DMXAA enhances the antitumor effects generated by therapeutic HPV DNA vaccines
por: Peng, Shiwen, et al.
Publicado: (2011)

Cervicovaginal cellular angiofibroma
por: Van Mulders, Sarah, et al.
Publicado: (2020)

The Cervicovaginal Mucus Barrier
por: Lacroix, Guillaume, et al.
Publicado: (2020)

Characteristics of the Cervicovaginal Microenvironment in Childbearing-Age Women with Different Degrees of Cervical Lesions and HR-HPV Positivity
por: ZHAI, QINGZHI, et al.
Publicado: (2021)

Co-administration with DNA encoding papillomavirus capsid proteins enhances the antitumor effects generated by therapeutic HPV DNA vaccination
por: Yang, Benjamin, et al.
Publicado: (2015)

Novel intravaginal nanomedicine for the targeted delivery of saquinavir to CD4(+) immune cells
por: Yang, Sidi, et al.
Publicado: (2013)

Irreversible electroporation of locally advanced pancreatic cancer transiently alleviates immune suppression and creates a window for antitumor T cell activation
por: Scheffer, Hester J., et al.
Publicado: (2019)

Combination of apigenin treatment with therapeutic HPV DNA vaccination generates enhanced therapeutic antitumor effects
por: Chuang, Chi-Mu, et al.
Publicado: (2009)

Optimized DNA electroporation for primary human T cell engineering
por: Zhang, Zhang, et al.
Publicado: (2018)

Absence of Effect of Intravaginal Miconazole, Clindamycin, Nonoxynol‐9, and Tampons on the Pharmacokinetics of an Anastrozole/Levonorgestrel Intravaginal Ring
por: Nave, Rüdiger, et al.
Publicado: (2017)

Control of HPV-associated tumors by innovative therapeutic HPV DNA vaccine in the absence of CD4+ T cells
por: Peng, Shiwen, et al.
Publicado: (2014)

Cervicovaginitis, etiología y diagnóstico
por: Moreno García, Antonio
Publicado: (1996)

Cannot write session to /tmp/vufind_sessions/sess_rgr72hi7u60fccp476dgpaekmn